Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: Results of a large population-based dutch cohort

Journal of Investigative Dermatology

Volumn 130, Issue 4, 2010, Pages 962-967

  Wakkee, Marlies ^a   Herings, Ron M C ^a,b   Nijsten, Tamar ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b PHARMO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; ETRETIN; FUMARIC ACID DERIVATIVE; INFLIXIMAB; METHOTREXATE; TOPICAL AGENT;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY RISK; FEMALE; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PSORIASIS; PUVA; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC THERAPY;

ACUTE DISEASE; ADULT; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PSORIASIS; RISK FACTORS;

EID: 77949524465     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.321     Document Type: Article

References (31)

1. Aronow WS (2003) Silent MI. Prevalence and prognosis in older patients diagnosed by routine electrocardiograms. Geriatrics 58: 636-840.
2. Brauchli YB, Jick SS, Miret M, Meier CR (2009) Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol 160:1048-1056
3. Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ 82:1-406
4. Cohen AD, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh DY et al. (2007) Psoriasis and the metabolic syndrome. Acta Derm Venereol 87:506-509
5. De Torbal A, Boersma E, Kors JA, van Herpen G, Deckers JW, van der Kuip DA et al. (2006) Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J 27:729-736
6. Dutch Heart Association Nederlandse Hartstichting. http://www. hartstichting.nl (File Hart-en vaatziekton in Nederland 2005). Accessed 18 September 2009
7. Erkens JA, Panneman MM, Klungel OH, van den Boom G, Prescott MF, Herings RM (2005) Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoe-pidemiol Drug Saf 14:795-803
8. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735-1741
9. Hammad TA, McAdams MA, Feight A, Iyasu S, Dal Pan GJ (2008) Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf 17:1197-1201
10. Herings RM, Leufkens HG, Vandenbroucke JP (2000) Acute myocardial infarction and prior antibiotic use. JAMA 284:2998-2999
11. Herings RM, Urquhart J, Leufkens HG (1999) Venous thromboembolism among new users of different oral contraceptives. Lancet 354:127-128
12. Kaye JA, Li L, Jick SS (2008) Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 159:895-902
13. Kimball AB, Gladman D, Gelfand JM, Gordon K, Horn EJ, Korman NJ et al. (2008) National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 58:1031-1042
14. Kurd SK, Gelfand JM (2009) The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 60:218-224
15. Lau HS, de Boer A, Beuning KS, Porsius A (1997) Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 50:619-625
16. Lindegard B (1986) Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 172:298-304
17. McDonald CJ, Calabresi P (1973) Occlusive vascular disease in psoriatic patients. N Engl J Med 288:912
18. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829-835
19. Nijsten T, Rolstad T, Feldman SR, Stern RS (2005) Members of the national psoriasis foundation: more extensive disease and better informed about treatment options. Arch Dermatol 141:19-26
20. Nijsten T, Wakkee M (2009) Complexity of the association between psoriasis and comorbidities. J Invest Dermatol 129:1601-1603
21. Pharmo (http://www.pharmo.nl). (Accessed on 10 January 2009)
22. Sattar N, McConnachie A, Shaper AG et al. (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371:1927-1935
23. Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA et al. (2008) The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol 35:387-393
24. Stern RS, Lange R (1988) Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 91:197-201
25. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9:136-139
26. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453-1457
27. Wakkee M, Meier W, Neumann HAM, Herings RMC, Nijsten T (2009) Psoriasis may not be an independent predictor for the use of cardiovascular and antidiabetic drugs: results from a 5-year prevalence study. Acta Derm Venereol 89:476-483
28. Wakkee M, Nijsten T (2009) Comorbidities in dermatology. Dermatol Clin 27:137-47, vi
29. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA (2007) Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 190:1-9
30. WHO (1987) WHO. International Classification of Diseases, 9th revision, Clinical Modification, and HIV Infection Codes Addendum (rev. nr. 1). Geneva, Switzerland: WHO
31. WHO (1999) WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: WHO